# V52 Queue: Therapeutic-Path Synthesis

Status: in-progress

V52 uses the active-time block machine, but its first value-complete target is a
therapeutic-path synthesis that combines V37 findings, restored OpenGWAS access,
and V51 structural context without reopening broad public-data discovery.

## Timing

- Block start UTC: 2026-07-10T09:43:31Z
- Active target: 6h cumulative active time
- Active session intervals:
  - 2026-07-10T09:43:31Z - open
- Wall-clock span start UTC: 2026-07-10T09:43:31Z

## Environment And Remote

- `origin`: https://github.com/sleibach/multiple-sclerosis-auto-research.git
- Local HEAD at start: `f9bbebcd25926ab8438dfe1d3fa5ecc108048183`
- `origin/main` at start: `f9bbebcd25926ab8438dfe1d3fa5ecc108048183`
- OpenGWAS token: renewed and active; POST-only checker returned HTTP 200 on
  `gwasinfo` and `tophits`; decoded expiry `2026-07-24 08:00 UTC`.
- SAP_AI_CORE_API_KEY: present; Claude/Gemini/RPT health check PASS.
- AlphaFold DB client and structural gate: to be verified in iteration guard.

## Backlog

| item | status | note |
|---|---|---|
| Write therapeutic-path synthesis report | done | `docs/reports/THERAPEUTIC_PATH_V52.md`; headline: monitoring/stratification is the honest near-term impact; no target is intervention-grade. |
| Structure-informed chr1 review: GPR25 | done | V51 AlphaFold record plus V17/V19 direction/druggability confirms structurally plausible but causally unresolved and chemically immature. |
| Structure-informed chr1 review: KIF21B | done | Retrieved AlphaFold DB `AF-O75037-F1` v6; motor-domain context is structurally interpretable but restoration/up-function direction keeps target closed. |
| Restored-OpenGWAS catch-up inventory | done | `docs/workups/genetics/RESTORED_OPENGWAS_CATCHUP_V52.md`; token active; bounded confirmed-locus rerun only. |
| Restored-OpenGWAS smoke rerun for genetics scripts | done | `scripts/v14_susie_coloc_confirmed_loci.py` reran POST-only `/ld/matrix` routes; no target verdict changed. |
| Therapeutic contradiction/convergence check | todo | Revisit therapeutic-relevant external records for true contradictions; do not treat external sources as evidence. |
| Validation-readiness tie-in | todo | Note what Gafson/Karolinska validation would make clinically actionable. |
| Guard and push iteration | in-progress | V47 provenance, V51 structural, external index, SAP health, status freshness, and size/tmp guards pass as of 2026-07-10T09:55:38Z; commit/push next. |
| Structure-informed PTGER4 triage | todo | Check whether any existing structure context could matter; likely no because closure is signal/direction, not structure. |
| Restored-OpenGWAS ZMIZ1 bounded direction handoff | todo | Inventory whether a POST-only bounded rerun can sharpen ZMIZ1 without broad discovery. |
| Public-facing therapeutic summary card | todo | Compact medical-team handoff after report stabilizes. |

## Per-Iteration Notes

- 2026-07-10T09:43:31Z: V52 started. OpenGWAS `.env` override uses renewed JWT;
  POST-only checker passed (`gwasinfo`, `tophits`) with expiry
  `2026-07-24 08:00 UTC`. Remote aligned at `f9bbebcd`. SAP AI Core health
  check passed for Claude/Gemini/RPT.
- 2026-07-10T09:50:02Z: Wrote `docs/reports/THERAPEUTIC_PATH_V52.md`, added
  KIF21B AlphaFold DB structural record (`O75037`) and context note, reran
  V19 chr1 local reanalysis and V14 confirmed-locus SuSiE-coloc with restored
  OpenGWAS POST-only access. Therapeutic headline: monitoring/stratification is
  the strongest near-term impact; chr1 remains real biology but not
  intervention-grade.
- 2026-07-10T09:55:38Z: Guard checkpoint passed: provenance gate, structural
  synthetic fixtures, structural record audit, external Markdown/index linters,
  SAP AI Core health, V52-aware status freshness, tracked-file size guard, and
  tracked-`tmp/` guard. Preparing first V52 commit and push.
